The Cerebral Amyloid Angiopathy Treatment Market is rapidly becoming one of the most watched segments in the neurodegenerative and vascular disorder landscape. Long overshadowed by Alzheimer's and Parkinson's, Cerebral Amyloid Angiopathy (CAA) is now drawing global attention thanks to technological advances, increased diagnostic accuracy, and a growing elderly population. According...